{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05933603",
            "orgStudyIdInfo": {
                "id": "1908864846v2"
            },
            "secondaryIdInfos": [
                {
                    "id": "R33HL151254",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R33HL151254"
                }
            ],
            "organization": {
                "fullName": "University of Arizona",
                "class": "OTHER"
            },
            "briefTitle": "Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome",
            "officialTitle": "Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome",
            "acronym": "MOSAIC",
            "therapeuticArea": [
                "Rare Diseases",
                "Other"
            ],
            "study": "medications-for-obstructive-sleep-apnea-to-improve-cognition-in-children-with-down-syndrome"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-26",
            "studyFirstSubmitQcDate": "2023-06-26",
            "studyFirstPostDateStruct": {
                "date": "2023-07-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-18",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Arizona",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institutes of Health (NIH)",
                    "class": "NIH"
                },
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is an open-label study of the combination of atomoxetine and oxybutynin (ato-oxy) in children with Down syndrome and obstructive sleep apnea (OSA) documented by polysomnography (PSG). Participants will receive ato-oxy for 6 months. Ato-oxy dose will be 5 mg oxybutynin and 0.5mg/kg/day (max 40 mg) atomoxetine. Dosing of the study treatment will occur approximately 30 minutes prior to bedtime. Participants who withdraw from the study will not be replaced.\n\nStudy participants will undergo eligibility screening that will include an initial screening to determine whether non- PSG enrollment criteria are met, followed by a 1 night in-lab PSG and health-related quality of life (HRQOL) and cognitive assessment for participants who qualify based on non-PSG criteria. For participants who are eligible and enroll in the study, the screening PSG night will serve as the baseline measure for apnea hypopnea index (AHI) and other PSG endpoints. On the final night of dosing for ato-oxy participants will return for inpatient PSG and health-related quality of life assessment and cognitive assessment. The primary efficacy endpoint is the change in obstructive AHI from baseline."
        },
        "conditionsModule": {
            "conditions": [
                "Obstructive Sleep Apnea",
                "Down Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 36,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Ato-oxy",
                    "type": "EXPERIMENTAL",
                    "description": "0.5 mg/kg (max 40 mg) atomoxetine and 5 mg oxybutynin",
                    "interventionNames": [
                        "Drug: Atomoxetine and Oxybutynin (ato-oxy)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Atomoxetine and Oxybutynin (ato-oxy)",
                    "description": "0.5 mg/kg atomoxetine (max 40 mg) and 5 mg oxybutynin by mouth nightly",
                    "armGroupLabels": [
                        "Ato-oxy"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "obstructive apnea-hypopnea index (oAHI)",
                    "description": "change in number of obstructive apneas and hypopneas per hour on polysomnography from baseline (% change)",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Obstructive Sleep Apnea-18 score (OSA-18)",
                    "description": "Change in OSA-18 (a measure of health-related quality of life) from baseline. The OSA-18 score ranges from 18 to 136, with lower scores indicating better health-related quality of life.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Paired Associates Learning test",
                    "description": "Change in Paired Associate Learning test total errors (a measure of memory) from baseline",
                    "timeFrame": "6 months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Pediatric Quality of Life Inventory (PedsQL) total score",
                    "description": "Change in PedsQL total score (a measure of health-related quality of life) from baseline. The PedsQL score ranges from 0-100, with higher scores indicating better health-related quality of life.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Processing speed",
                    "description": "Change in processing speed as measured by A-MAP from baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Verbal IQ",
                    "description": "Change in verbal IQ as measured by the Kaufman Brief IQ Test 2 from baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Verbal memory",
                    "description": "Change in verbal memory as measured by A-MAP from baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Language",
                    "description": "Change in child vocalizations/ hour as measured by LENA",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Caregiver Global Impression of Change",
                    "description": "Change in Caregiver Global Impression of Change from baseline. This will be assessed on a seven point scale answering the question: Since the start of this therapy, my child's overall status is: 1. Very much improved; 2. Much improved; 3. Minimally Improved; 4. No change; 5. Minimally worse; 6. Much worse or 7. Very much worse.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "N1 sleep percentage",
                    "description": "Change in N1 sleep percentage on polysomnography from baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "REM sleep percentage",
                    "description": "Change in REM sleep percentage on polysomnography from baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "N3 sleep percentage",
                    "description": "Change in N3 sleep percentage on polysomnography from baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Arousal Index",
                    "description": "change in number of arousals per hour on polysomnography from baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Executive Function",
                    "description": "Change in Behavior Rating Inventory of Executive Function (BRIEF) Global Executive Composite from baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Adaptive function",
                    "description": "Change in Vineland 3 adaptive behavior composite scale from baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Attention Deficit Hyperactivity Disorder symptoms",
                    "description": "Change in Conners-3 Attention Deficit Hyperactivity Disorder Index from baseline",
                    "timeFrame": "6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Male or female participants between 6 to 17 years of age, inclusive, at the Screening Visit.\n2. Known diagnosis of Down syndrome (trisomy 21, but not translocation or mosaicism)\n\nExclusion Criteria:\n\n1. Presence of central sleep apnea on polysomnography (central AHI \u2265 5)\n2. Currently using and adherent to positive airway pressure therapy (\\>4 hours per night for 70% of nights in the past 30 days based on device download or parent report)\n3. Monoamine oxidase inhibitor use\n4. Urinary retention\n5. Prematurity \\< 32 weeks estimated gestational age\n6. Seizure disorder\n7. Untreated or inadequately treated hypothyroidism\n8. Significant traumatic brain injury\n9. Congenital heart disease and not cleared to participate by the patient's cardiologist\n10. History of current, untreated depression\n11. History of liver disease\n12. 3+ or greater tonsillar hypertrophy\n13. Positive urine pregnancy test\n14. Hypoxemia independent of respiratory events on baseline polysomnography (\u22655 minutes with oxygen saturation \\<90%)\n15. Presence of central sleep apnea on baseline polysomnography (central AHI \u2265 5)\n\n3. Absence of OSA defined as total AHI \\<5 on baseline polysomnography",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "6 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "University of Arizona",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "86721",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lauren Melcher",
                            "role": "CONTACT",
                            "phone": "520-403-0383",
                            "email": "lmelcher@arizona.edu"
                        },
                        {
                            "name": "Daniel Combs, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "De-identified data will be made available via a database such as sleepdata.org.",
            "timeFrame": "Data will be made available following primary analysis and publication of primary study results."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001049",
                    "term": "Apnea"
                },
                {
                    "id": "D000012891",
                    "term": "Sleep Apnea Syndromes"
                },
                {
                    "id": "D000020181",
                    "term": "Sleep Apnea, Obstructive"
                },
                {
                    "id": "D000004314",
                    "term": "Down Syndrome"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000012120",
                    "term": "Respiration Disorders"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000012818",
                    "term": "Signs and Symptoms, Respiratory"
                },
                {
                    "id": "D000020919",
                    "term": "Sleep Disorders, Intrinsic"
                },
                {
                    "id": "D000020920",
                    "term": "Dyssomnias"
                },
                {
                    "id": "D000012893",
                    "term": "Sleep Wake Disorders"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000008607",
                    "term": "Intellectual Disability"
                },
                {
                    "id": "D000019954",
                    "term": "Neurobehavioral Manifestations"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000000015",
                    "term": "Abnormalities, Multiple"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000025063",
                    "term": "Chromosome Disorders"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22010",
                    "name": "Sleep Apnea, Obstructive",
                    "asFound": "Obstructive Sleep Apnea",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4361",
                    "name": "Apnea",
                    "asFound": "Apnea",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15694",
                    "name": "Sleep Apnea Syndromes",
                    "asFound": "Sleep Apnea",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7489",
                    "name": "Down Syndrome",
                    "asFound": "Down Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14957",
                    "name": "Respiration Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15623",
                    "name": "Signs and Symptoms, Respiratory",
                    "relevance": "LOW"
                },
                {
                    "id": "M22242",
                    "name": "Parasomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M22654",
                    "name": "Sleep Disorders, Intrinsic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22655",
                    "name": "Dyssomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M15696",
                    "name": "Sleep Wake Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11589",
                    "name": "Intellectual Disability",
                    "relevance": "LOW"
                },
                {
                    "id": "M21826",
                    "name": "Neurobehavioral Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M14",
                    "name": "Abnormalities, Multiple",
                    "relevance": "LOW"
                },
                {
                    "id": "M23023",
                    "name": "Chromosome Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000005419",
                    "term": "Oxybutynin"
                },
                {
                    "id": "D000069445",
                    "term": "Atomoxetine Hydrochloride"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018759",
                    "term": "Adrenergic Uptake Inhibitors"
                },
                {
                    "id": "D000014179",
                    "term": "Neurotransmitter Uptake Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000010276",
                    "term": "Parasympatholytics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000018727",
                    "term": "Muscarinic Antagonists"
                },
                {
                    "id": "D000018680",
                    "term": "Cholinergic Antagonists"
                },
                {
                    "id": "D000018678",
                    "term": "Cholinergic Agents"
                },
                {
                    "id": "D000064804",
                    "term": "Urological Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M227675",
                    "name": "Oxybutynin",
                    "asFound": "Arm description",
                    "relevance": "HIGH"
                },
                {
                    "id": "M414",
                    "name": "Atomoxetine Hydrochloride",
                    "asFound": "Equipment",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M13189",
                    "name": "Parasympatholytics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20801",
                    "name": "Muscarinic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20758",
                    "name": "Cholinergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20760",
                    "name": "Cholinergic Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Urol",
                    "name": "Urological Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}